Patient enrolment completed in Cynata Therapeutics’ Phase II clinical trial of CYP-001 in high risk acute graft versus host disease ... Read More The post Cynata completes enrolment in Phase II trial of CYP-001 in life threatening aGvHD appeared first on Stockhead .